Arteris (AIP) 10% holder Bayview Legacy sells 125,976 shares

Rhea-AI Filing Summary

Bayview Legacy, LLC, a 10% owner of Arteris, Inc. (AIP), reported open-market sales of a total of 125,976 shares of common stock on July 6, 2026. The sales were executed in three tranches at weighted average prices of $35.065, $36.2365, and $37.0705 per share.

The trades were made pursuant to a Rule 10b5-1 trading plan adopted by K. Charles Janac, the manager of Bayview Legacy, LLC, on December 12, 2025. Janac is deemed to have voting and dispositive power over the shares held by Bayview Legacy, and he has separately filed a Form 4 reflecting the same transactions.

Insider Trade Summary 10b5-1

Net Seller: 125,976 shares ($4,509,185)

Net Sell 3 txns

Insider Bayview Legacy, LLC

Role null

Sold 125,976 shs ($4.51M)

Type	Security	Shares	Price	Value
Sale	Common Stock	29,490	$37.0705	$1.09M
Sale	Common Stock	27,908	$36.2365	$1.01M
Sale	Common Stock	68,578	$35.065	$2.40M

Holdings After Transaction: Common Stock — 8,525,557 shares (Indirect, See Footnote)

Footnotes (1)

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.66 to $37.58 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.66 to $36.655 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.64 to $35.63 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Total shares sold: 125,976 shares First tranche shares: 68,578 shares Second tranche shares: 27,908 shares +2 more

5 metrics

Total shares sold 125,976 shares Open-market sales on July 6, 2026

First tranche shares 68,578 shares Common Stock sold at $35.065 per share

Second tranche shares 27,908 shares Common Stock sold at $36.2365 per share

Third tranche shares 29,490 shares Common Stock sold at $37.0705 per share

10b5-1 plan adoption date December 12, 2025 Plan adopted by K. Charles Janac for Bayview Legacy, LLC

Key Terms

Rule 10b5-1 trading plan, beneficial ownership, weighted average sale price, voting and dispositive power

4 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan that was adopted..."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

beneficial ownership financial

"given his beneficial ownership of the reported security through Bayview Legacy, LLC..."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price."

voting and dispositive power financial

"is deemed to have voting and dispositive power over the shares..."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/08/2026 - 04:16 PM Accepted by SEC EDGAR 07/08/2026 - 04:15 PM Learn about SEC filing dates

FAQ

What insider transaction did Arteris (AIP) report in this Form 4?

Arteris (AIP) reported that Bayview Legacy, LLC sold 125,976 common shares. The 10% owner executed three open-market sales on July 6, 2026, at weighted average prices between $35.065 and $37.0705 per share under a pre-established trading plan.

Who is Bayview Legacy, LLC in relation to Arteris (AIP)?

Bayview Legacy, LLC is a 10% owner of Arteris, Inc. (AIP). It holds Arteris common stock, and its manager, K. Charles Janac, is deemed to have voting and dispositive power over these shares, giving him beneficial ownership through the LLC structure.

Were the Arteris (AIP) insider sales made under a 10b5-1 plan?

Yes, the Arteris (AIP) share sales were made under a Rule 10b5-1 plan. The plan was adopted on December 12, 2025 by K. Charles Janac, as manager of Bayview Legacy, LLC, indicating the July 6, 2026 sales were pre-arranged.

What prices did Bayview Legacy, LLC receive for Arteris (AIP) shares?

Bayview Legacy, LLC sold Arteris (AIP) shares at weighted average prices from about $35.07 to $37.07. Individual tranches priced at $35.065, $36.2365, and $37.0705, with underlying trades within specified intraday price ranges.

Did K. Charles Janac personally file a Form 4 for Arteris (AIP)?

Yes, K. Charles Janac separately filed a Form 4 for Arteris (AIP). The footnotes state he reported the same transactions in his individual capacity because he beneficially owns the securities through Bayview Legacy, LLC, which he controls as its manager.

How many Arteris (AIP) share sales are disclosed in this Form 4?

The Form 4 discloses three separate open-market sale transactions in Arteris (AIP) stock. They cover 68,578 shares, 27,908 shares, and 29,490 shares, respectively, all executed on July 6, 2026 by Bayview Legacy, LLC.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bayview Legacy, LLC

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CALIFORNIA 95008

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/06/2026		S(1)(2)		29,490	D	$37.0705(3)	8,525,557	I	See Footnote(4)
Common Stock	07/06/2026		S(1)(2)		27,908	D	$36.2365(5)	8,497,649	I	See Footnote
Common Stock	07/06/2026		S(1)(2)		68,578	D	$35.065(6)	8,429,071	I	See Footnote

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on December 12, 2025.

2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.

3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $36.66 to $37.58 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $35.66 to $36.655 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.64 to $35.63 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ K. Charles Janac	07/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)